Save your place

Sign in to WhoBought

Please try again later.

Immuneering Corporation (IMRX) institutional ownership

Market cap$121M SectorHealthcare
Funds holding · Q1 2026
94
reported IMRX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
53 buyers · 41 sellers

Immuneering Corporation (IMRX) price and institutional activity

Dates

Q1 2026

$0 bought by 53 investors
Marshall Wace, LLPMillennium Management LLC +51 more
$0 sold by 41 investors
Empery Asset Management, LPState Street +39 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Immuneering Corporation (IMRX) institutional activity · 94

Investor Type Est. change Change Δ Own Date
Empery Asset Management, LP · Exited
Change −2.7M Δ Own −100.0% Date Q1 2026
Empery Asset Management, LP Exited· Q1 2026 −2.7M −100.0% Q1 2026
State Street · Reduced
Change −2.1M Date Q1 2026
State Street Reduced· Q1 2026 −2.1M Q1 2026
Marshall Wace, LLP · Added
Change +1.3M Date Q1 2026
Marshall Wace, LLP Added· Q1 2026 +1.3M Q1 2026
Millennium Management LLC · Added
Change +1.1M Date Q1 2026
Millennium Management LLC Added· Q1 2026 +1.1M Q1 2026
Blue Owl Capital Holdings LP · Exited
Change −665K Δ Own −100.0% Date Q1 2026
Blue Owl Capital Holdings LP Exited· Q1 2026 −665K −100.0% Q1 2026
Summit Financial, LLC · New
Change +377K Date Q1 2026
Summit Financial, LLC New· Q1 2026 +377K Q1 2026
Citadel Advisors LLC Added· Q1 2026 +357K +394.5% Q1 2026
Connor, Clark & Lunn Investment Management Ltd. · Added
Change +268K Date Q1 2026
Connor, Clark & Lunn Investment Management Ltd. Added· Q1 2026 +268K Q1 2026
Morgan Stanley · Reduced
Change −194K Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −194K Q1 2026
UBS Group AG · Added
Change +186K Date Q1 2026
UBS Group AG Added· Q1 2026 +186K Q1 2026
Qube Research & Technologies Ltd · Exited
Change −166K Δ Own −100.0% Date Q1 2026
Qube Research & Technologies Ltd Exited· Q1 2026 −166K −100.0% Q1 2026
T. Rowe Price Associates · Reduced
Change −165K Date Q1 2026
T. Rowe Price Associates Reduced· Q1 2026 −165K Q1 2026
Wellington Management Group LLP · New
Change +156K Date Q1 2026
Wellington Management Group LLP New· Q1 2026 +156K Q1 2026
Woodline Partners LP · Exited
Change −150K Δ Own −100.0% Date Q1 2026
Woodline Partners LP Exited· Q1 2026 −150K −100.0% Q1 2026
Squarepoint Ops LLC · Added
Change +134K Date Q1 2026
Squarepoint Ops LLC Added· Q1 2026 +134K Q1 2026
Data through Q1 2026 · filed May 15, 2026
15 of 94

Famous investor activity in Immuneering Corporation (IMRX)

Immuneering Corporation (IMRX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Gengos Andrew · Officer Grant (A) 650K
Owned 650K Trade date Jul 16, 2026 Filed date Jul 17, 2026
Gengos Andrew Officer Grant (A) 650K 650K Jul 16, 2026 Jul 17, 2026
Zeskind Benjamin J. · Director Buy +$11K
Price $4.56 Qty +2K Owned 2.3M ΔOwn +0.1% Trade date Jun 23, 2026 Filed date Jun 24, 2026
Zeskind Benjamin J. Director Buy $4.56 +2K +$11K 2.3M +0.1% Jun 23, 2026 Jun 24, 2026
Hall Brett Matthew · Officer Buy +$25K
Price $4.15 Qty +6K Owned 383K Trade date Jun 15, 2026 Filed date Jun 16, 2026
Hall Brett Matthew Officer Buy $4.15 +6K +$25K 383K Jun 15, 2026 Jun 16, 2026
Schall Thomas J. · Director Grant (A) 33K
Owned 33K Trade date Jun 11, 2026 Filed date Jun 11, 2026
Schall Thomas J. Director Grant (A) 33K 33K Jun 11, 2026 Jun 11, 2026
Hausman Diana · Director Grant (A) 33K
Owned 33K Trade date Jun 11, 2026 Filed date Jun 11, 2026
Hausman Diana Director Grant (A) 33K 33K Jun 11, 2026 Jun 11, 2026
Carpenter Robert J. · Director Grant (A) 33K
Owned 33K Trade date Jun 11, 2026 Filed date Jun 11, 2026
Carpenter Robert J. Director Grant (A) 33K 33K Jun 11, 2026 Jun 11, 2026
Keating Laurie · Director Grant (A) 33K
Owned 33K Trade date Jun 11, 2026 Filed date Jun 11, 2026
Keating Laurie Director Grant (A) 33K 33K Jun 11, 2026 Jun 11, 2026
Feinberg Peter · Director Grant (A) 33K
Owned 33K Trade date Jun 11, 2026 Filed date Jun 11, 2026
Feinberg Peter Director Grant (A) 33K 33K Jun 11, 2026 Jun 11, 2026
Neufeld Leah R. · Officer Grant (A) $16K
Price $4.29 Qty 4K Owned 30K Trade date Mar 13, 2026 Filed date Mar 17, 2026
Neufeld Leah R. Officer Grant (A) $4.29 4K $16K 30K Mar 13, 2026 Mar 17, 2026
Bookman Michael · Officer Grant (A) 176K
Owned 176K Trade date Feb 3, 2026 Filed date Feb 5, 2026
Bookman Michael Officer Grant (A) 176K 176K Feb 3, 2026 Feb 5, 2026
Brakewood Harold Eugene · Officer Grant (A) 140K
Owned 140K Trade date Feb 3, 2026 Filed date Feb 5, 2026
Brakewood Harold Eugene Officer Grant (A) 140K 140K Feb 3, 2026 Feb 5, 2026
Hall Brett Matthew · Officer Grant (A) 344K
Owned 344K Trade date Feb 3, 2026 Filed date Feb 5, 2026
Hall Brett Matthew Officer Grant (A) 344K 344K Feb 3, 2026 Feb 5, 2026
Matushansky Igor · Officer Grant (A) 140K
Owned 140K Trade date Feb 3, 2026 Filed date Feb 5, 2026
Matushansky Igor Officer Grant (A) 140K 140K Feb 3, 2026 Feb 5, 2026
Morales Mallory · Officer Grant (A) 140K
Owned 140K Trade date Feb 3, 2026 Filed date Feb 5, 2026
Morales Mallory Officer Grant (A) 140K 140K Feb 3, 2026 Feb 5, 2026
Neufeld Leah R. · Officer Grant (A) 140K
Owned 140K Trade date Feb 3, 2026 Filed date Feb 5, 2026
Neufeld Leah R. Officer Grant (A) 140K 140K Feb 3, 2026 Feb 5, 2026
15 of 32
15 of 32 Sign in to continue to older insider transactions.

Immuneering Corporation (IMRX) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Benjamin J. Zeskind 4.0M
% of shares outstanding 12.8% Filing date Jan 17, 2025
Benjamin J. Zeskind 4.0M 12.8% Jan 17, 2025
T. Rowe Price Associates 3.2M
% of shares outstanding 12.2% Filing date Feb 14, 2022
T. Rowe Price Associates 3.2M 12.2% Feb 14, 2022
Citadel Advisors LLC 2.1M
% of shares outstanding 7.8% Filing date Feb 14, 2022
Citadel Advisors LLC 2.1M 7.8% Feb 14, 2022
BlackRock Inc. 1.4M
% of shares outstanding 4.7% Filing date Apr 5, 2024
BlackRock Inc. 1.4M 4.7% Apr 5, 2024
4 of 4

Immuneering Corporation (IMRX) ownership FAQ

Who owns IMRX?

94 reporting institutions disclosed IMRX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.